tailieunhanh - Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro

Advanced or metastatic renal cell carcinoma (RCC) has a poor prognosis, because it is relatively resistant to conventional chemotherapy or radiotherapy. Treatments with human interferon-α2b alone or in combination with mammalian target of rapamycin (mTOR) inhibitors have led to only a modest improvement in clinical outcome. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN